| Stage | RSVR | % of rev | LYV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $46M | 100.00% | $7.7B | 100.00% | LYV ×168.25 |
| Gross profit | $29M | 64.45% | $1.9B | 25.34% | RSVR +39.1pp |
| Operating income | $10M | 22.66% | $522M | 6.81% | RSVR +15.9pp |
| Pre-tax income | $3M | 7.20% | $519M | 6.76% | RSVR +0.4pp |
| Net income | $2M | 4.83% | $403M | 5.25% | LYV +0.4pp |
| Stage | RSVR | LYV | Gap · A − B |
|---|---|---|---|
| Revenue | $46M100.00% | $7.7B100.00% | LYV ×168.25 |
| Gross profit | 64.45%$29M | 25.34%$1.9B | RSVR +39.1pp |
| Operating income | 22.66%$10M | 6.81%$522M | RSVR +15.9pp |
| Pre-tax income | 7.20%$3M | 6.76%$519M | RSVR +0.4pp |
| Net income |
| 4.83%$2M |
| 5.25%$403M |
| LYV +0.4pp |
No disclosed counterparties: LYV.
None